June 2001 – The CenterWatch Monthly : PDF
Sites Rate GSK, Merck and Biogen the Top Sponsors
Results of the recent CenterWatch survey of sponsor-site relationship quality show that GlaxoSmithKline, Merck, Biogen, Pfizer and Eli Lilly are the top five companies rated by the investigative sites with which they work.
Overall, however, the quality of sponsor relationships with investigative sites has declined since we last conducted our survey two years ago. Most sponsors appear to be failing to support those factors the sites consider to be most essential to study success.
FDA Complaints Against Investigative Sites Still Rising
FDA reports that the number of complaints filed against investigative sites for failure to compy with GCP in 2000 were 10% higher than the unprecedented number filed in 1999.
Compared to routine inspections, the FDA finds more serious violations of compliance with GCP when it investigates formal complaints. As an additional quality assurance practice, the agency is increasing its inspections of CRAs.
Also in this issue:
- CentreStage Europe: Defining the SMO Market in Europe
- Eye On: Ovarian Cancer